Search

Displaying results 8281 - 8290 of 10000 in total
  1. Drug

    Perastine

    go.drugbank.com/drugs/DB20513
    Experimental

    Perastine is a small molecule drug. The usage of the INN stem '-astine' in the name indicates that Perastine is a antihistaminic. Perastine has a monoisotopic molecular weight of 295.19 Da.

  2. Drug

    Fostedil

    go.drugbank.com/drugs/DB20574
    Experimental

    Fostedil is a small molecule drug. The usage of the INN stem '-dil' in the name indicates that Fostedil is a vasodilator. Fostedil has a monoisotopic molecular weight of 361.09 Da.

  3. Drug

    Stevaladil

    go.drugbank.com/drugs/DB20689
    Experimental

    Stevaladil is a small molecule drug. The usage of the INN stem '-dil' in the name indicates that Stevaladil is a vasodilator. Stevaladil has a monoisotopic molecular weight of 447.33 Da.

  4. Drug

    Meluadrine

    go.drugbank.com/drugs/DB20693
    Experimental

    Meluadrine is a small molecule drug. The usage of the INN stem '-drine' in the name indicates that Meluadrine is a sympathomimetic. Meluadrine has a monoisotopic molecular weight of 243.1 Da.

  5. Drug

    Bamirastine

    go.drugbank.com/drugs/DB21186
    Experimental

    Bamirastine is a small molecule drug. The usage of the INN stem '-astine' in the name indicates that Bamirastine is a antihistaminic. Bamirastine has a monoisotopic molecular weight of 527.29 Da.

  6. Drug

    Barmastine

    go.drugbank.com/drugs/DB21253
    Experimental

    Barmastine is a small molecule drug. The usage of the INN stem '-astine' in the name indicates that Barmastine is a antihistaminic. Barmastine has a monoisotopic molecular weight of 483.24 Da.

  7. Drug

    Zanoterone

    go.drugbank.com/drugs/DB21384
    Experimental

    Zanoterone is a small molecule drug. The usage of the INN stem '-terone' in the name indicates that Zanoterone is a antiandrogen. Zanoterone has a monoisotopic molecular weight of 416.21 Da.

  8. Drug

    Rogaratinib

    go.drugbank.com/drugs/DB15078
    Investigational

    Rogaratinib is under investigation in clinical trial NCT03762122 (Rogaratinib in Patients With Advanced Pretreated Squamous-cell Non-small Cell Lung Cancer (SQCLC)).

  9. Drug

    PF-04620110

    go.drugbank.com/drugs/DB14887
    Investigational

    PF-04620110 is under investigation in clinical trial NCT01146327 (A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects).

  10. Drug

    Spartalizumab

    go.drugbank.com/drugs/DB14892
    Investigational

    Spartalizumab is under investigation in clinical trial NCT02605967 (Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma).